Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,388 | -12,208 | -12,030 | -10,421 | -7,892 |
| Depreciation Amortization | 340 | 359 | 241 | 154 | 37 |
| Accounts receivable | N/A | N/A | 128 | 21 | 58 |
| Other Working Capital | 94 | 479 | 65 | -251 | 310 |
| Other Operating Activity | 5,309 | 1,241 | 1,091 | 730 | 722 |
| Operating Cash Flow | $-7,646 | $-10,130 | $-10,505 | $-9,767 | $-6,765 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -251 | -943 | -349 | -60 |
| Investing Cash Flow | $N/A | $-251 | $-943 | $-349 | $-60 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,911 | 1,322 | 8,927 | 17,456 | 7,261 |
| Other Financing Activity | -184 | -35 | -13 | -88 | -133 |
| Financing Cash Flow | $7,727 | $1,288 | $8,915 | $17,368 | $7,128 |
| Exchange Rate Effect | -12 | 2 | -6 | N/A | N/A |
| Beginning Cash Position | 5,530 | 14,621 | 17,160 | 9,908 | 9,605 |
| End Cash Position | 5,599 | 5,530 | 14,621 | 17,160 | 9,908 |
| Net Cash Flow | $70 | $-9,091 | $-2,540 | $7,252 | $304 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,646 | -10,130 | -10,505 | -9,767 | -6,765 |
| Capital Expenditure | N/A | -251 | -943 | -349 | -60 |
| Free Cash Flow | -7,646 | -10,381 | -11,448 | -10,116 | -6,825 |